GLAXOSMITHKLINE S.A.E |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.13 EGP | -0.20% |
|
-3.06% | -15.25% |
Quotes 5-day view
End-of-day quote Egyptian Exchange| 01/05/2024 | 02/05/2024 | 07/05/2024 | 08/05/2024 | 09/05/2024 | |
|---|---|---|---|---|---|
| Last | 30.08 £ | 31.08 £ | 31.4 £ | 30.19 £ | 30.13 £ |
| Volume | 9 013 | 13 224 | 12 765 | 25 948 | 14 871 |
| Change | +∞% | +3.32% | +1.03% | -3.85% | -0.20% |
| Opening | 30.08 | 30.08 | 31.08 | 31.40 | 30.19 |
| High | 30.90 | 31.50 | 32.00 | 31.39 | 30.68 |
| Low | 29.96 | 30.00 | 31.00 | 30.01 | 30.00 |
Performance
| 1 day | -0.20% | ||
| 1 week | -3.06% | ||
| Current month | +0.17% | ||
| 1 month | -3.86% | ||
| 3 months | -20.02% | ||
| 6 months | -5.49% | ||
| Current year | -15.25% | ||
| 1 year | -5.78% | ||
| 3 years | +10.73% | ||
| 10 years | +124.35% |
Volumes
marketsDaily volume
14 871
Avg. Volume 20 sessions
34 948
Avg. Volume 20 sessions EGP
1 052 983.24
Avg. Volume 20 sessions USD
22 237.95
Record volume 1
763 890
Record volume 2
619 100
Record volume 3
594 277
Capital turnover ratio
0.00
Float rotation
0.01
Basic data
Capitalization (EGP)
2 513 789 100
Capitalization (USD)
53 088 712
Net sales (EGP)
2 240 219 838
Net sales (USD)
47 311 203
Free-Float
2.91 %
Free-Float capitalization (EGP)
73 271 928
Free-Float capitalization (USD)
1 547 430
Average Daily Capital Traded
0.04%
Highs and lows
1 week
30.00
32.00
1 month
29.1936.00
Current year
28.2047.50
1 year
26.2647.50
3 years
16.6647.50
5 years
5.7747.50
10 years
0.0047.50
Indicators
Moving average 5 days
30.58
Moving average 20 days
31.31
Moving average 50 days
33.60
Moving average 100 days
35.41
Price spread / (MMA5)
+1.49%
Price spread / (MMA20)
+3.92%
Price spread / (MMA50)
+11.52%
Price spread / (MMA100)
+17.52%
STIM
RSI 9 days
39.79
RSI 14 days
41.06
Sector Comparison - Other Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -0.20% | -3.06% | -15.25% | -5.78% | 53.09M | ||
| -1.50% | +3.41% | +30.38% | +74.34% | 684B | ||
| +0.07% | +1.16% | +26.51% | +54.70% | 568B | ||
| +0.04% | +0.43% | -4.36% | -7.26% | 361B | ||
| -0.13% | +2.00% | +19.30% | +10.31% | 329B | ||
| +0.22% | -1.86% | +3.73% | +9.79% | 284B | ||
| +0.31% | +2.66% | +16.70% | +4.65% | 240B | ||
| +1.97% | +4.94% | +8.78% | +0.41% | 208B | ||
| +1.26% | +3.59% | -7.93% | -19.66% | 200B | ||
| -0.87% | -0.37% | +7.68% | +32.48% | 166B | ||
| -0.60% | +0.72% | -2.71% | -26.87% | 159B | ||
| +1.23% | +3.32% | +5.09% | -4.53% | 127B | ||
| +1.07% | +3.81% | +24.09% | +25.28% | 91.83B | ||
| +0.45% | +2.16% | -12.41% | -34.38% | 91.1B | ||
| +2.14% | +1.82% | -18.58% | -15.55% | 82.18B | ||
| +3.60% | -2.13% | +39.08% | +21.50% | 66.22B | ||
| Average | +1.02% | +1.44% | +7.51% | +7.46% | ||
| Weighted average by Cap. | +0.83% | +1.40% | +13.55% | +22.60% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -15.25% | ||
| 2023 | -6.84% | ||
| 2022 | +23.58% | ||
| 2021 | +82.08% | ||
| 2020 | -14.17% | ||
| 2018 | -100.00% | ||
| 2017 | +81.72% | ||
| 2016 | -11.39% | ||
| 2015 | -10.00% | ||
| 2014 | -20.11% | ||
| 2013 | +53.22% | ||
| 2012 | +0.42% | ||
| 2011 | -39.24% | ||
| 2010 | +18.18% | ||
| 2009 | +24.72% | ||
| 2008 | -47.68% | ||
| 2007 | +0.89% | ||
| 2006 | +104.33% | ||
| 2005 | +6.65% |
- Stock Market
- Equities
- BIOC Stock
- Quotes GlaxoSmithKline S.A.E